Newsroom | 4579 results

Sorted by: Latest

Radiology
-

Varex Announces Financial Results for Third Quarter Fiscal Year 2025

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the third quarter of fiscal year 2025. 3QFY25 Summary Revenues of $203 million GAAP gross margin 33% | Non-GAAP gross margin* 34% GAAP operating margin (40)% | Non-GAAP operating margin* 8% GAAP net loss $(2.15) per diluted share | Non-GAAP net earnings* $0.18 per diluted share Cash flow from operations was $8 million Sunny Sanyal, Chief Executive Officer, stated, "We ar...
-

QT Imaging Announces Continuous Strong Revenue Growth and Enhanced Balance Sheet in the Second Quarter 2025

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (OTCQB: QTIH) (“QT Imaging” or the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the three and six months ended June 30, 2025, and provided a business update. “We are pleased to report that the strong business momentum from the first quarter carried through Q2, and in many ways, we are even more energized by the signi...
-

Riassunto: HistoSonics annuncia l’acquisizione da 2,25 miliardi di dollari da parte di un consorzio di investitori di altissimo livello

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, l’impresa che ha creato il sistema di istotripsia Edison® e l’innovativa piattaforma per la terapia con questa tecnica, oggi ha annunciato l’acquisizione della partecipazione di maggioranza guidata dal management da parte di un consorzio di investitori pubblici e privati rinomati globalmente – K5 Global, Bezos Expeditions e Wellington Management nonché altri investitori preesistenti e nuovi. L’operazione assegna a HistoSonics un valore di circa 2,25 mi...
-

HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors...
-

HistoSonics gibt Übernahme durch Konsortium aus hochkarätigen Investoren im Wert von 2,25 Mrd. USD bekannt

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, Entwickler des Edison® Histotripsy-Systems und einer neuartigen Histotripsy-Therapieplattform, gab heute bekannt, dass eine Gruppe weltweit anerkannter privater und öffentlicher Investoren, darunter K5 Global, Bezos Expeditions, Wellington Management sowie weitere neue und bestehende Investoren, unter Führung des Managements eine Mehrheitsbeteiligung erworben hat. Die Transaktion bewertet HistoSonics mit rund 2,25 Mrd. USD und versetzt das Unternehmen...
-

Samenvatting: HistoSonics kondigt overname van 2,25 miljard dollar aan door consortium van vooraanstaande investeerders

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, de ontwikkelaar van het Edison® histotripsy-systeem en een nieuw histotripsy-behandelplatform, heeft vandaag bekendgemaakt dat een consortium van wereldwijd erkende particuliere en publieke investeerders, waaronder K5 Global, Bezos Expeditions, Wellington Management en andere nieuwe en bestaande investeerders, een meerderheidsbelang in het bedrijf heeft verworven. Met de transactie die HistoSonics op ongeveer 2,25 miljard dollar waardeert, kan het bedr...
-

Resumen: Un consorcio de inversores de primer orden adquiere HistoSonics por 2250 millones de dólares

MINNEÁPOLIS--(BUSINESS WIRE)--HistoSonics, desarrollador del sistema de histotricia Edison® y de la novedosa plataforma de terapia de histotricia, ha anunciado hoy la adquisición de una participación mayoritaria liderada por la dirección de un sindicato de inversores privados y públicos reconocidos en todo el mundo, incluyendo K5 Global, Bezos Expeditions, Wellington Management y otros inversores nuevos y existentes. La transacción otorga a HistoSonics un valor aproximado de 2250 millones de dó...
-

HistoSonics annonce son acquisition pour 2,25 milliards de dollars par un consortium d’investisseurs de premier plan

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, développeur de l’Edison® Histotripsy System et d’une nouvelle plateforme de thérapie histotripsique, a annoncé aujourd’hui l’acquisition d’une participation majoritaire par un consortium d’investisseurs privés et publics de renommée mondiale, dont K5 Global, Bezos Expeditions, Wellington Management et d’autres investisseurs nouveaux et existants. Cette transaction valorise HistoSonics à environ 2,25 milliards de dollars et positionne l’entreprise pour...
-

CIVIE and Upson Regional Medical Center Partner to Streamline Radiology Services In Georgia

DALLAS--(BUSINESS WIRE)--CIVIE, a leading provider of cloud-native radiology workflow solutions, and Upson Regional Medical Center today announced a strategic partnership to streamline imaging services across the hospital campus in Georgia. Upson Regional Medical Center, a community-based hospital in Thomaston, Georgia, will utilize CIVIE’s flagship radiology program, RadPod, to modernize imaging services, integrate solutions, and improve patient experiences. The partnership reinforces Upson’s...
-

New Lantern Expands AI Radiology Platform with Mammography and PET/CT Viewers

SAN FRANCISCO--(BUSINESS WIRE)--New Lantern releases two new specialized viewer modes....